Navigation Links
Amgen To Present At The Baird Healthcare Conference
Date:8/31/2012

THOUSAND OAKS, Calif., Aug. 31, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate in the Baird Healthcare Conference on Thursday, Sept. 6, 2012, at The New York Palace Hotel in New York City, beginning at 1:24 p.m. Eastern Daylight Time. Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.  Follow us on www.twitter.com/amgen.


CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Eric Hylengren, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
2. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
3. Amgen Completes Acquisition of KAI Pharmaceuticals
4. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
5. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
6. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
7. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
8. Amgen to Present at the Baird Growth Stock Conference
9. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
10. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
11. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... Wolfmet 3D  printed tungsten collimator manufactured by M&I Materials ... combine to progress molecular radiotherapy imaging. In molecular ... to accurately quantify the radiation absorbed by those patients undergoing ... of this radiotherapy treatment has been available — that is, ... ...
(Date:7/5/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade cell and tissue hypothermic storage ... that it has reached an agreement with WAVI Holding ... modify its existing credit facility effective June 30, 2017. ... to exchange its existing $4.25 million credit facility, including ...
(Date:6/30/2017)... (AVACEN) announced the publication of new research in the peer-reviewed Fibromyalgia ... AVACEN Treatment Method to significantly reduce the widespread pain symptom ... ... ... to 400 million people worldwide according to The National Fibromyalgia Association. ...
Breaking Medicine Technology:
(Date:7/21/2017)... Norwalk, Connecticut (PRWEB) , ... July 21, 2017 , ... ... data from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in ... quarter of 2017, and up 15% from the 20 announced deals in the year-ago ...
(Date:7/21/2017)... NJ (PRWEB) , ... July 21, 2017 , ... ... has received a $5,000 grant from the C. R. Bard Foundation, ... Day Center at Somerset Hills , a service available through the nonprofit home ...
(Date:7/21/2017)... ... ... West Dermatology is pleased to announce the newest addition to their Fresno, ... will join West Dermatology’s large network of medical and cosmetic dermatology practices, bringing with ... more. She graduated from the University of Florida College of Medicine Physician Assistant Program ...
(Date:7/20/2017)... ... , ... TransPixel Volume 2 is a set of transitions that create a ... isolates horizontal and vertical lines of pixels and sorts their pixels by darkness, brightness, ... and can be changed using a drop-down menu. Create amazing and artistic transitions using ...
(Date:7/20/2017)... ... 2017 , ... Coats Rose, P.C. , a business ... expansion to the Midwest with the establishment of the firm’s new Cincinnati office. ... of counsels, John Peck and Robert Bruns, will establish and anchor Coats Rose’s ...
Breaking Medicine News(10 mins):